Divergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats

被引:17
作者
Bian, Xiaocui [1 ]
Zhou, Renlong [1 ]
Yang, Yuting [1 ]
Li, Peiying [1 ]
Hang, Yannan [1 ]
Hu, Youmin [2 ]
Yang, Liqun [1 ]
Wen, Daxiang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Anesthesiol, Shanghai 200001, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Lab Room Physiol Pathophysiol & Pharmacol, Shanghai 200025, Peoples R China
关键词
dezocine; contractile tension; propulsive motility; small smooth muscle intestine; KAPPA-OPIOID RECEPTORS; INDUCED BOWEL DYSFUNCTION; POSTOPERATIVE PAIN; PORCINE ILEUM; MU; MANAGEMENT; PATHOPHYSIOLOGY; INHIBITION; MOTILITY; AGONISTS;
D O I
10.7150/ijms.12616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Opioid induced bowel dysfunction is the most common side effect of preoperatively administrated morphine, fentanyl and its derivative. However, the influence of dezocine on intestinal mobility is rarely reported. This study was designed to investigate the effects of dezocine, morphine and sufentanil on both intestinal smooth muscle contraction and propulsion in rats. Methods: Contractile tension and frequency of isolated rat small intestine smooth muscle were measured using tension transducer after incubation with different concentrations of dezocine, morphine and sufentanil. The propulsive rate of methylene blue in rat intestinal tract was measured 30 minutes after intraperitoneal injection of morphine, sufentanil and dezocine. Percent of change in contractile tension and contraction frequency compared to baseline level were calculated to evaluate muscle contraction. Propulsive rate of methylene blue was calculated as the percentage of methylene blue moving distance in intestinal tract compared to the length of the small intestine. Results: Morphine and sufentanil significantly increased the contractile tension of isolated small intestine smooth muscle at high doses. The contraction frequency did not change significantly among the 3 tested doses. Increasing the dose of dezocine from 1.7 mg. L-1 to 10.2 mg. L-1 did not change either the contractile tension or the contraction frequency. The propulsive rate of methylene blue in intestinal tract was significantly decreased after the treatment with morphine, sufentanil and dezocine (45.6%, 43.7%, and 42.1% respectively) compared to control group(57.1%), while the difference among the 3 drug groups were not significant. Conclusion: Morphine and sufentanil may dose dependently increase the contractile tension and contraction ability of isolated rat small intestine smooth muscle, while dezocine has no significant effect on intestine smooth muscle contraction. However, all these opioids might impair small intestinal propulsion.
引用
收藏
页码:848 / 852
页数:5
相关论文
共 25 条
[1]   Opioids: a two-faced Janus [J].
Ahlbeck, Karsten .
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (02) :439-448
[2]   Opioid-Induced Bowel Dysfunction Pathophysiology and Management [J].
Brock, Christina ;
Olesen, Soren Schou ;
Olesen, Anne Estrup ;
Frokjaer, Jens Brondum ;
Andresen, Trine ;
Drewes, Asbjorn Mohr .
DRUGS, 2012, 72 (14) :1847-1865
[3]   Delta-opioid receptor mRNA expression and immunohistochemical localization in porcine ileum [J].
Brown, DR ;
Poonyachoti, S ;
Osinski, MA ;
Kowalski, TR ;
Pampusch, MS ;
Elde, RP ;
Murtaugh, MP .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (07) :1402-1410
[4]   ACTION OF OPIATES ON GASTROINTESTINAL FUNCTION [J].
BUENO, L ;
FIORAMONTI, J .
BAILLIERES CLINICAL GASTROENTEROLOGY, 1988, 2 (01) :123-139
[5]   REGULATORY ROLE OF ENTERIC KAPPA-OPIOID RECEPTORS IN HUMAN COLONIC MOTILITY [J].
CHAMOUARD, P ;
KLEIN, A ;
MARTIN, E ;
ADLOFF, M ;
ANGEL, F .
LIFE SCIENCES, 1993, 53 (14) :1149-1156
[6]  
COHEN RI, 1993, ANESTH ANALG, V77, P533
[7]  
Feng Zhi-Ying, 2008, Zhejiang Da Xue Xue Bao Yi Xue Ban, V37, P271
[8]   Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans [J].
Holzer, P .
NEUROSCIENCE LETTERS, 2004, 361 (1-3) :192-195
[9]   Central & peripheral nervous systems - Treatment of opioid-induced gut dysfunction [J].
Holzer, Peter .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) :181-194
[10]  
Junker Uwe, 2009, Med Monatsschr Pharm, V32, P175